Matthew Scott Harris - 31 Jul 2024 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Medical Officer
Signature
/s/ Andrew Shutterly as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
31 Jul 2024
Net transactions value
+$8,039
Form type
4
Filing time
01 Aug 2024, 17:40:41 UTC
Previous filing
05 Feb 2024
Next filing
28 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Award $8,039 +1,486 +2.8% $5.41 55,119 31 Jul 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2024 through July 31, 2024.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2024.

Remarks:

Exhibit 24 - Power of Attorney.